New trial aims to stop pneumonia in ventilated kids with nebulized antibiotic
NCT ID NCT06488794
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests if giving a nebulized antibiotic (colistimethate sodium) can prevent pneumonia in children who are on breathing machines. About 400 children aged 1 month to 14 years will receive either the drug or a placebo twice daily for up to 7 days. The goal is to see if the treatment reduces the number of children who develop ventilator-associated pneumonia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENTILATOR ASSOCIATED PNEUMONIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••